Business Description
Hwail Pharm Co Ltd
ISIN : KR7061250007
Compare
Compare
Traded in other countries / regions
061250.Korea IPO Date
2002-04-18Description
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 19.52 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -3.89 | |||||
| Interest Coverage | 10.86 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.29 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32.3 | |||||
| 3-Year EBITDA Growth Rate | 27.3 | |||||
| 3-Year EPS without NRI Growth Rate | -22.9 | |||||
| 3-Year Book Growth Rate | 1.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.2 | |||||
| 9-Day RSI | 53.02 | |||||
| 14-Day RSI | 51.32 | |||||
| 6-1 Month Momentum % | -15.67 | |||||
| 12-1 Month Momentum % | -44.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.19 | |||||
| Quick Ratio | 9.44 | |||||
| Cash Ratio | 6.08 | |||||
| Days Inventory | 110.75 | |||||
| Days Sales Outstanding | 85.49 | |||||
| Days Payable | 13.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.3 | |||||
| Shareholder Yield % | -0.5 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 9.11 | |||||
| Operating Margin % | 1.5 | |||||
| Net Margin % | -0.93 | |||||
| FCF Margin % | -10.42 | |||||
| ROE % | -0.63 | |||||
| ROA % | -0.59 | |||||
| ROIC % | 1.25 | |||||
| ROC (Joel Greenblatt) % | -1.35 | |||||
| ROCE % | -0.7 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.7 | |||||
| PB Ratio | 0.5 | |||||
| Price-to-Tangible-Book | 0.5 | |||||
| Price-to-Operating-Cash-Flow | 6.61 | |||||
| EV-to-EBIT | -31.66 | |||||
| EV-to-EBITDA | -47.33 | |||||
| EV-to-Revenue | 0.32 | |||||
| EV-to-FCF | -3.11 | |||||
| Price-to-Projected-FCF | 0.73 | |||||
| Price-to-Median-PS-Value | 0.72 | |||||
| Price-to-Net-Current-Asset-Value | 0.79 | |||||
| Price-to-Net-Cash | 1.76 | |||||
| Earnings Yield (Greenblatt) % | -3.17 | |||||
| FCF Yield % | -12.59 | |||||
| Forward Rate of Return (Yacktman) % | -15.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hwail Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 122,450.63 | ||
| EPS (TTM) (â‚©) | -16 | ||
| Beta | 0.7 | ||
| Volatility % | 50.44 | ||
| 14-Day RSI | 51.32 | ||
| 14-Day ATR (â‚©) | 59.174273 | ||
| 20-Day SMA (â‚©) | 1211.9 | ||
| 12-1 Month Momentum % | -44.2 | ||
| 52-Week Range (â‚©) | 1016 - 2265 | ||
| Shares Outstanding (Mil) | 80.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hwail Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hwail Pharm Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hwail Pharm Co Ltd Frequently Asked Questions
What is Hwail Pharm Co Ltd(XKRX:061250)'s stock price today?
The current price of XKRX:061250 is â‚©1259.00. The 52 week high of XKRX:061250 is â‚©2265.00 and 52 week low is â‚©1016.00.
When is next earnings date of Hwail Pharm Co Ltd(XKRX:061250)?
The next earnings date of Hwail Pharm Co Ltd(XKRX:061250) is .
Does Hwail Pharm Co Ltd(XKRX:061250) pay dividends? If so, how much?
Hwail Pharm Co Ltd(XKRX:061250) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers